FDA inspection

LEK Pharmaceuticals dd: FDA inspection ending Oct 25, 2019

FDA inspection 1108260 · Voluntary Action Indicated (VAI) · Ljubljana

Key facts

Inspection ID 1108260
Firm LEK Pharmaceuticals dd
FEI number 3002807460
Address Verovskova ulica 57
City Ljubljana
Fiscal year 2020
Inspection end date Oct 25, 2019
Classification Voluntary Action Indicated (VAI)
Project area Generic Drug Evaluation
Product type Drugs

At a glance

  • 1–9 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 10–99 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections